The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
May 10th 2024
In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
May 21, 2024
Register Now!
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
23rd Annual International Congress on the Future of Breast Cancer® West
July 12-13, 2024
Register Now!
25th Annual International Lung Cancer Congress®
July 25-27, 2024
Register Now!
2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference
View More
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
Large Study Shows Mixed Results in Comparison of DBT and Digital Mammography
May 31st 2023In a large retrospective study involving over 523,000 digital breast tomosynthesis (DBT) exams and over one million digital mammography (DM) exams, researchers found that DBT was associated with significantly lower recall rates but showed no advantage over DM in the diagnosis of interval or advanced breast cancer.
Mammography Study Finds No Significant Link Between Breast Density and Breast Cancer Prognosis
May 26th 2023In a study involving over 1,100 women diagnosed with breast cancer, researchers found that 48.7 percent of women alive or dead from other causes at a median follow-up of 11.7 years had moderately dense breasts. They also found that 46 percent of women who died from breast cancer at a median-follow-up of 5.3 years had moderately dense breasts.
Digital Mammography Meta-Analysis Suggests AI Performs as Well as Radiologists
May 24th 2023Six reader studies on digital mammography revealed a pooled sensitivity rate of 80.8 percent for stand-alone artificial intelligence (AI) in comparison to 72.4 percent for radiologist assessment while seven historic cohort studies showed a 75.8 percent pooled sensitivity rate for stand-alone AI versus 72.6 percent for radiologist interpretation of digital mammography.
Do the New USPSTF Recommendations Go Far Enough on Mammography Screening?
May 11th 2023The United States Preventive Services Task Force (USPSTF) has drawn praise for lowering the age threshold for initial mammography screening from 50 to 40 years of age in updated draft recommendations for breast cancer screening, but critics warn that biennial screening is not sufficient for higher-risk populations.
New ACR Guidelines Emphasize Earlier Mammography Screening for High-Risk Women
May 4th 2023While calling for a universal breast cancer risk assessment by the age of 25, the American College of Radiology (ACR) emphasized that ascertaining screening needs prior to the age of 40 is particularly important in high-risk populations such as Black women, who are 42 percent more likely to die from breast cancer in comparison to non-Hispanic White women.
What a New Study Reveals About AI, Bias and Mammography Assessment
May 2nd 2023Regardless of experience level, radiologists are likely to be affected by automation bias when utilizing adjunctive artificial intelligence (AI) for mammography interpretation, according to newly published research.
Does Timing of Imaging Affect Interpretation of Contrast-Enhanced Mammography?
April 19th 2023Earlier initiation of imaging after contrast administration with contrast-enhanced mammography may provide better visibility of lesions and conspicuity against background parenchymal enhancement, according to new research presented at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.
Study Looks at Contributing Factors to Incomplete Follow-Up for BI-RADS 3 Findings
April 6th 2023Emerging research suggests that 29 percent of patients with index breast magnetic resonance imaging (MRI) exams, 45 percent of Asian women and 30 percent of women living in the highest disadvantaged neighborhoods did not have follow-up imaging after a BI-RADS 3 diagnosis.
Can ChatGPT Provide Appropriate Information on Mammography and Other Breast Cancer Screening Topics?
April 5th 2023Researchers found that ChatGPT offered appropriate responses to 22 out of 25 patient-oriented questions on mammography screening, dense breasts, BI-RADS scoring and other topics related to breast cancer screening and prevention.
Automated Breast Ultrasound: Is it a Viable Second-Look Option for Women with Dense Breasts?
April 4th 2023Emerging research shows the adjunctive use of automated breast ultrasound with mammography has similar sensitivity for breast cancer detection as adjunctive handheld ultrasound but may offer reduced false-positive rates in women with dense breasts.
Study: Emerging AI Platform for DBT Shows 23 Percent Increase in Breast Cancer Detection Rate
March 23rd 2023In a recent video interview, Kathy Schilling, M.D., discussed findings from a study of ProFound AI, an adjunctive artificial intelligence (AI) software for digital breast tomosynthesis (DBT), that demonstrated a 23 percent increase in breast cancer detection in comparison to DBT alone.
FDA Issues Final Rule on National Breast Density Notification for Mammography Reports
March 9th 2023As part of updates to the Mammography Quality Standards Act (MQSA) of 1992, the Food and Drug Administration (FDA) has issued a final rule that requires the inclusion of breast density assessment in mammography reports starting on September 10, 2024.
Study: AI Improves Cancer Detection Rate for Digital Mammography and Digital Breast Tomosynthesis
March 6th 2023Comparing year-long findings with and without adjunctive artificial intelligence (AI) at a breast cancer screening program in Spain, researchers found the combination of digital breast tomosynthesis and AI had a 92.5 percent accuracy for diagnosing cancer in patients with elevated risk.
Cancer Screenings and COVID-19: What a New Study Shows
February 27th 2023New research from the American Cancer Society comparing pre-pandemic cancer screening prevalence to the second year of the COVID-19 pandemic in the United States showed a 1.1 million decrease in breast cancer screenings, a 4.4 million decrease in cervical cancer screening and a 600,000 decrease in prostate cancer screenings.